重症急性胰腺炎镇痛治疗中国专家共识(2022版)

Chinese expert consensus on analgesic treatment of severe acute pancreatitis (2022 edition)

  • 摘要: 重症急性胰腺炎中,镇痛治疗除了能缓解疼痛,还可能影响患者预后。因此,镇痛治疗作为重症急性胰腺炎综合治疗的一部分,越来越受到重视。然而,重症急性胰腺炎患者的镇痛治疗仍存在诸多挑战,且目前没有共识性的建议。亚洲急危重症协会中国腹腔重症协作组专家针对重症急性胰腺炎中疼痛和镇痛治疗对疾病和预后的影响、镇痛药物和镇痛方式选择等方面讨论并提出21条临床最关注的问题,综合循证医学证据以及临床经验制订《重症急性胰腺炎镇痛治疗中国专家共识(2022版)》,旨在为临床医师提供参考和建议,以期改善患者预后。

     

    Abstract: In severe acute pancreatitis (SAP), analgesic treatment not only relieves pain, but also affects outcomes of patient. Therefore, analgesic treatment has drawn increasing attention as part of the comprehensive treatment strategies in SAP. However, analgesic treatment of SAP is faced with many challenges, and consensus suggestions are nonexistent. Experts from the Chinese Abdominal Intensive Care Association of Asia Society of Emergency and Critical Care Medicine discuss and propose 21 critical issues of clinical concern regarding pain and analgesic treatment on disease and patient outcomes, choice of analgesics, and analgesic methods in SAP and formulated the Chinese expert consensus on analgesic treatment of severe acute pancreatitis (2022 edition) based on medical evidence and experts clinical experiences, with the aim of providing guidance for clinical practice and improving patient outcomes.

     

/

返回文章
返回